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Cofactor Selectivity in Methylmalonyl Coenzyme A Mutase, a
Model Cobamide-Dependent Enzyme
Olga M. Sokolovskaya,a,b Kenny C. Mok,a Jong Duk Park,a* Jennifer L. A. Tran,a* Kathryn A. Quanstrom,a* Michiko E. Tagaa
aDepartment of Plant & Microbial Biology, University of California Berkeley, Berkeley, California, USA
bDepartment of Chemistry, University of California Berkeley, Berkeley, California, USA
ABSTRACT Cobamides, a uniquely diverse family of enzyme cofactors related to vi-
tamin B12, are produced exclusively by bacteria and archaea but used in all domains
of life. While it is widely accepted that cobamide-dependent organisms require spe-
cific cobamides for their metabolism, the biochemical mechanisms that make cob-
amides functionally distinct are largely unknown. Here, we examine the effects of
cobamide structural variation on a model cobamide-dependent enzyme, methylma-
lonyl coenzyme A (CoA) mutase (MCM). The in vitro binding affinity of MCM for cob-
amides can be dramatically influenced by small changes in the structure of the
lower ligand of the cobamide, and binding selectivity differs between bacterial or-
thologs of MCM. In contrast, variations in the lower ligand have minor effects on
MCM catalysis. Bacterial growth assays demonstrate that cobamide requirements of
MCM in vitro largely correlate with in vivo cobamide dependence. This result under-
scores the importance of enzyme selectivity in the cobamide-dependent physiology
of bacteria.
IMPORTANCE Cobamides, including vitamin B12, are enzyme cofactors used by or-
ganisms in all domains of life. Cobamides are structurally diverse, and microbial
growth and metabolism vary based on cobamide structure. Understanding cobam-
ide preference in microorganisms is important given that cobamides are widely used
and appear to mediate microbial interactions in host-associated and aquatic environ-
ments. Until now, the biochemical basis for cobamide preferences was largely un-
known. In this study, we analyzed the effects of the structural diversity of cobamides
on a model cobamide-dependent enzyme, methylmalonyl-CoA mutase (MCM). We
found that very small changes in cobamide structure could dramatically affect the
binding affinity of cobamides to MCM. Strikingly, cobamide-dependent growth of a
model bacterium, Sinorhizobium meliloti, largely correlated with the cofactor binding
selectivity of S. meliloti MCM, emphasizing the importance of cobamide-dependent
enzyme selectivity in bacterial growth and cobamide-mediated microbial interac-
tions.
KEYWORDS Sinorhizobium meliloti, chemical diversity, cobalamin, cobamides,
enzyme selectivity
Cobalamin, commonly referred to as vitamin B12, is a versatile enzyme cofactor usedby organisms in all domains of life. In humans, cobalamin is essential for methio-
nine synthesis and the breakdown of fatty acids, amino acids, and cholesterol (1, 2).
Bacteria and archaea additionally use cobalamin and related cofactors, cobamides, for
deoxyribonucleotide synthesis (3), metabolism of various carbon and energy sources
(4–17), synthesis of secondary metabolites (18–25), sensing light (26), and other pro-
cesses (15–17, 27–32). The finding that 86% of bacterial species encode at least one
cobamide-dependent enzyme in their genome (33) demonstrates the prevalence of
cobamide-dependent metabolisms. Widespread use of these cofactors can be attrib-
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uted to their chemical versatility, as they facilitate challenging chemical reactions,
including radical-initiated rearrangements, methylation reactions, and reductive cleav-
age of chemical bonds (34, 35).
All cobamides share the same core structure (Fig. 1): a corrin ring that coordinates
a cobalt ion, a variable “upper” axial ligand (R in Fig. 1), and a pseudonucleotide that
is covalently attached to the corrin ring through an aminopropanol linker (36) or an
ethanolamine linker, in the case of norcobamides (37, 38). The major differences among
cobamides are in the structure of the nucleotide base, more commonly referred to as
the lower axial ligand for its ability to coordinate the central cobalt ion. In cobalamin,
the lower ligand is 5,6-dimethylbenzimidazole (Fig. 1, boxed); in other naturally occur-
ring cobamides, different benzimidazoles, phenolics, and purines constitute the lower
ligand (Table 1 and Fig. 2C) (39–43). Phenolyl cobamides are distinct in that they lack
the coordinate bond between the lower ligand and cobalt ion.
While cobamides containing different lower ligands share the same chemically
N
NN
N
Co+
CONH2
CONH2
CONH2H2NOC
H2NOC
H2NOC
O
NH
O
P
O
O
R
O
HO
N
OH
O
N
H
R = 5’-deoxyadenosine, methyl,
       cyanide, water 
FIG 1 The structure of cobalamin. The lower ligand, boxed, varies in other cobamides. Cobinamide, a
cobamide precursor, lacks a nucleotide base (delineated by the wavy line).
TABLE 1 Abbreviations used for cobamides and upper axial ligands
Abbreviation or prefix Cobamide name or upper ligand
Abbreviation
Cbl Cobalamin
[5-MeBza]Cba 5-Methylbenzimidazolylcobamide
[Bza]Cba Benzimidazolylcobamide
[5-OHBza]Cba 5-Hydroxybenzimidazolylcobamide
[Cre]Cba para-Cresolylcobamide
[Phe]Cba Phenolylcobamide
[Ade]Cba Adeninylcobamide
[2-MeAde]Cba 2-Methyladeninylcobamide
[Pur]Cba Purinylcobamide
[7-MeBza]Cba 7-Methylbenzimidazolylcobamide
[7-AmBza]Cba 7-Aminobenzimidazolylcobamide
[6-AzaBza]Cba 6-Azabenzimidazolylcobamide
[3-DeazaAde]Cba 3-Deazaadeninylcobamide
[6-MePur]Cba 6-Methylpurinylcobamide
Prefix
Ado 5=-Deoxyadenosine
CN Cyanide
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reactive moieties, specifically the cobalt center and methyl or 5=-deoxyadenosyl upper
axial ligands, they are nonetheless functionally distinct. Culture-based studies have
shown that only a subset of cobamides supports a given bacterial metabolism, and
uptake or production of other cobamides can inhibit growth (39, 44–49). The require-
ments of bacteria for particular cobamides are notable given the diversity of cobamides
present in host-associated and environmental samples (40–42), coupled with the
absence of de novo cobamide biosynthesis in more than half of bacteria (33). Despite
the biological relevance of cobamide structure, and the prevalence of cobamide use
among bacteria (33, 50–52), little is understood about the biochemical mechanisms by
which cobamides differentially impact microbial physiology.
The effect of lower ligand structure on the biochemistry of cobamide-dependent
enzymes has been studied to a limited extent. In “base-on” enzymes, the lower ligand
base coordinates the central cobalt ion of the cobamide, as drawn in Fig. 1 (53–55).
Because the lower ligand is part of the catalytic center of the enzyme, lower ligand
structure can influence catalysis through a variety of mechanisms (56–58), and cobam-
ides unable to form an intramolecular coordinate bond are catalytically inactive in
base-on enzymes (59, 60). In contrast, in “base-off” enzymes the lower ligand is
bound by the enzyme more than 10 Å away from the active site (20, 61–70). In a
subset of base-off enzymes, referred to as “base-off/His-on,” a histidine residue from
the protein coordinates the cobalt ion in place of the lower ligand (61, 63). Despite
its distance from the reactive center, lower ligand structure affects the activity of
base-off enzymes, as evidenced by the cobamide cofactor selectivity of methionine
synthase (71), methylmalonyl coenzyme A (CoA) mutase (MCM) (60, 72), reductive
dehalogenases (49), and other enzymes (59, 72, 73). However, the mechanisms by
which lower ligand structure affects the biochemistry of base-off cobamide-
dependent enzymes remain unclear.
As MCM is one of the most abundant cobamide-dependent enzymes in bacterial
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FIG 2 Binding of diverse cobamides to SmMCM (see also Fig. S1). (A and B) Fluorescence decrease of SmMCM when
reconstituted with benzimidazolyl cobamides (blue), cobinamide (black), phenolyl cobamides (green), and purinyl cob-
amides (orange). Data points represent the mean and standard deviation for three technical replicates from a single
experiment. (C) Kd values for different cobamides, reported as the average and standard deviation for three or more
independent experiments, each consisting of technical triplicates. “n. d.,” not determined, indicating that binding was too
weak to determine Kd.
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genomes (33), and one of the two cobamide-dependent enzymes in humans, we have
chosen to study the cobamide selectivity of MCM as a model for base-off/His-on
enzymes, all of which share a structurally conserved B12-binding domain (63, 74). MCM
catalyzes the interconversion of (R)-methylmalonyl-CoA and succinyl-CoA, a bidirec-
tional reaction used in propionate metabolism (12, 75, 76), catabolism of branched
amino acids and odd-chain fatty acids (76, 77), polyhydroxybutyrate degradation (78),
secondary metabolite biosynthesis (79), and autotrophic carbon dioxide fixation (4, 80).
MCM-dependent pathways have been harnessed industrially for the bioproduction of
propionate, bioplastics, biofuels, and antibiotics (81–88).
The presence of a cobamide lower ligand is required for MCM activity, as evidenced
by the observation that adenosylcobinamide, a cobamide intermediate lacking a lower
ligand (Fig. 1), does not support MCM activity in vitro (89). Three studies provide
evidence that MCM is selective for cobamides with particular lower ligands. First,
MCM from Propionibacterium shermanii was found to have different apparent Km
values for cobamides, increasing from AdoCbl to Ado[Bza]Cba to Ado[Ade]Cba
(refer to Table 1 for full names of cobamides), and MCM from sheep had a higher
apparent Km for Ado[Bza]Cba than AdoCbl (72). Second, P. shermanii MCM had a
lower apparent Km for Ado[Cre]Cba than AdoCbl (60). Third, in Sinorhizobium
meliloti bacteroids, MCM activity was highest with AdoCbl, intermediate with
Ado[Bza]Cba, and absent with Ado[Ade]Cba (90). Each of these studies includes
only one or two cobamides other than cobalamin, and understandably so; cobam-
ides are difficult to obtain in high quantities and must be purified from large
volumes of bacterial cultures. Because of this, the response of MCM orthologs to the
full diversity of cobamides has not been explored, and the mechanistic basis of
cobamide selectivity remains unclear.
To investigate the mechanisms by which diverse lower ligands affect MCM function,
we conducted in vitro binding and activity assays with MCM from S. meliloti (SmMCM).
We discovered major differences in the binding affinities of eight naturally occurring
cobamides for SmMCM, while cobamide structure affected enzyme activity to a lesser
extent. Using six additional cobamides, five of which are novel analogs that have not
been observed in nature or described previously, we identified structural elements of
lower ligands that are determinants of binding to SmMCM. To probe the hypothesis
that enzyme selectivity influences bacterial growth, we characterized the cobamide
dependence of S. meliloti growth in vivo. By bridging the results of in vitro biochemistry
of three bacterial MCM orthologs and the cobamide-dependent growth phenotypes of
S. meliloti, we have elucidated molecular factors that contribute to the cobamide-
dependent physiology of bacteria.
RESULTS
Lower ligand structure influences cobamide binding to MCM.We chose SmMCM
as a model to examine how lower ligand structure influences MCM function based on
previous work demonstrating its activity as a homodimer encoded by a single gene (91,
92). We purified eight naturally occurring cobamides for in vitro studies of this protein
and chemically adenosylated each cobamide to produce the biologically active form
used by MCM for catalysis. Previous studies showed that binding of cobamides to P.
shermanii MCM can be detected in vitro by measuring quenching of intrinsic protein
fluorescence (89). We found that the fluorescence of purified, His-tagged SmMCM also
decreased in a dose-dependent manner when the protein was reconstituted with
increasing concentrations of AdoCbl (Fig. 2A). The equilibrium dissociation constant
(Kd) derived from these measurements, 0.03 0.02 M (Fig. 2C), is 6-fold lower than the
Kd reported for P. shermanii MCM (89). Adocobinamide also bound SmMCM, as was
observed with P. shermanii MCM (89), albeit with over 10-fold-reduced affinity com-
pared to cobalamin (Fig. 2A and C).
We next measured binding of other benzimidazolyl cobamides to SmMCM and
found that Ado[5-MeBza]Cba and Ado[Bza]Cba, the cobamides most structurally similar
to AdoCbl, also bound the enzyme. However, the absence of one or two methyl groups,
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respectively, in the lower ligands of these cobamides caused a decrease in binding
affinity relative to AdoCbl (Fig. 2A and C). Strikingly, no binding of Ado[5-OHBza]Cba to
SmMCMwas detected at low-micromolar concentrations. To rule out the possibility that
Ado[5-OHBza]Cba binds SmMCM but does not cause a fluorescence quench, we used
an alternative, filtration-based, binding assay and observed little to no binding of
Ado[5-OHBza]Cba to SmMCM at micromolar concentrations (see Fig. S1A and B in the
supplemental material).
We expanded our analysis of SmMCM-cobamide binding selectivity to include
cobamides from other structural classes. Both of the phenolyl cobamides tested,
Ado[Cre]Cba and Ado[Phe]Cba, bound SmMCM with affinities similar to those of
cobalamin and other benzimidazolyl cobamides (Fig. 2B and C). In contrast, the purinyl
cobamides Ado[2-MeAde]Cba and Ado[Ade]Cba had lower affinities for SmMCM
compared to most benzimidazolyl cobamides (Fig. 2B and C): Ado[2-MeAde]Cba
bound SmMCM with 20-fold lower affinity than cobalamin, and Ado[Ade]Cba did
not bind to any significant extent at micromolar concentrations (verified by the
filtration assay [Fig. S1C]). Interestingly, for all three classes of lower ligands, the
presence of a methyl substituent promoted binding relative to other cobamides of
the same structural class.
Bacterial MCM orthologs have distinct selectivity. To test whether cofactor-
binding selectivity is a general phenomenon across bacterial MCM orthologs, we
compared the cobamide-binding profile of SmMCM to that of MCM orthologs from
Escherichia coli (EcMCM) and Veillonella parvula (VpMCM). Activity of EcMCM with
AdoCbl has been reported both in vivo and in vitro, although its physiological role in E.
coli remains unclear (82, 93). Annotations for two MCM homologs are present in the
genome of V. parvula, and we purified the one that exhibits MCM activity when
expressed in S. meliloti (see Materials and Methods). Because S. meliloti produces
cobalamin (94), E. coli produces [2-MeAde]Cba when provided with cobinamide (95),
and V. parvula produces [Cre]Cba (96), we expected that each ortholog should have
distinct cobamide selectivity. Indeed, EcMCM had highest affinity for its native cobam-
ide, Ado[2-MeAde]Cba (Fig. 3A and C). All other cobamides bound with 2- to 3-fold
reduced affinities relative to Ado[2-MeAde]Cba. Similarly, VpMCM had a higher affinity
for Ado[Cre]Cba, its native cobamide, than AdoCbl (Fig. 3B and C). VpMCM also bound
Ado[2-MeAde]Cba and Ado[Bza]Cba with similar affinities. We observed differences
between the total changes in fluorescence among cobamides with similar Kd values.
This is not unexpected, as protein fluorescence is highly sensitive to local environment
and may be affected by subtle conformational differences.
We constructed a sequence alignment of MCM orthologs from diverse organisms
known to produce or use various cobamides, in search of amino acid residues that
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FIG 3 Binding selectivity of diverse MCM orthologs (see also Fig. S2). Fluorescence binding assays with E. coli MCM (A) and V. parvula MCM (B). Data
points and error bars represent the mean and standard deviation, respectively, for technical triplicates from a single experiment; each replicate consisted
of an independent cobamide dilution. Kd values from the fitted curves in panels A and B are reported in panel C; error values reflect the standard error
of the curve fit. Kd values for VpMCM binding to Ado[Cre]Cba and AdoCbl and for EcMCM binding to all cobamides were reproduced in independent
experiments.
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could account for differences in cobamide binding (Fig. S2A). The B12-binding domains
of diverse MCM orthologs had high overall amino acid identity (38 to 70%). Cases of low
identity correlated with differences in the structural configuration of MCM, which
occurs in different organisms as a homodimer (92, 93, 97, 98), heterodimer (61, 99–101),
or heterotetramer (80, 102) (Fig. S2B). We focused our analysis on residues immediately
surrounding the lower ligand in the available crystal structure of Homo sapiens MCM
(97) (HsMCM) (Fig. S2A, triangles). For the most part, these residues are highly
conserved between orthologs. Interestingly, however, HsMCM residues Phe638,
Phe722, and Ala731, which are conserved in SmMCM, are replaced with the more
polar residues Tyr, Tyr, and Ser, respectively, in EcMCM (Fig. S2A), which has a
higher affinity for purinyl cobamides. Introducing mutations in SmMCM and EcMCM
to test the importance of these residues proved challenging, as it resulted in
reduced protein solubility and overall impaired cobamide binding (data not shown).
Whether or not these residues covary with cobamide selectivity across other MCM
orthologs is difficult to interpret because the cobamide selectivity of MCM from
most organisms is unknown.
The lower ligand of cobamides modulates MCM reaction kinetics. We reconsti-
tuted SmMCM with saturating amounts of each of the four cobamides that bound with
highest affinity and measured conversion of (R)-methylmalonyl-CoA to succinyl-CoA
under steady-state conditions. Interestingly, the substrate Km was nearly invariable
among the cobamides tested (Fig. 4). Turnover was highest with AdoCbl (26 1 s1)
and 2- to 3-fold lower with other cobamides. Thus, all of the cobamides tested
supported SmMCM catalysis with modest differences in kcat. This finding is consistent
with a previous observation that adenosylcobinamide-GDP, a cobamide precursor with
an extended nucleotide loop and a guanine base, supported activity of P. shermanii
MCM with only slight catalytic impairment compared to AdoCbl (103).
MCM-dependent growth of S. meliloti correlates with the binding selectivity of
SmMCM for benzimidazolyl and purinyl cobamides, but not phenolyl cobamides.
To assess whether the cobamide-dependent growth of S. meliloti reflects MCM selec-
tivity as observed in vitro, we cultured S. meliloti under conditions that require MCM
activity. Examination of metabolic pathways encoded in the S. meliloti genome using
the KEGG database (104) suggests that the degradation of branched amino acids
isoleucine and valine to succinyl-CoA, an intermediate of the citric acid cycle, requires
MCM. Indeed, growth of S. meliloti on L-isoleucine and L-valine as the only carbon
sources was dependent on the presence of the bhbA gene, which encodes MCM (91)
(Fig. S3).
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FIG 4 Activity of Sinorhizobium meliloti MCM with different cobamide cofactors. (A) Succinyl-CoA formation was detected using a coupled spectrophotometric
assay (138). DTNB, dithionitrobenzoate (Ellman’s reagent); TNB, thionitrobenzoate; CoA, coenzyme A. (B) Michaelis-Menten kinetic analysis of SmMCM
reconstituted with various cobamides. Data points and error bars represent the mean and standard deviation, respectively, for three technical replicates from
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We constructed an S. meliloti strain incapable of synthesizing cobalamin and lacking
cobamide-dependent enzymes other than MCM to ensure that differential growth
could be attributed solely to MCM selectivity for added cobamides (see Materials and
Methods). We cultivated this strain with L-isoleucine and L-valine as sole carbon sources
in medium supplemented with different cobamides in their cyanylated (CN) form,
which is the form typically used for in vivo growth assays. Under these growth
conditions, the maximum growth yield (optical density at 600 nm [OD600]) achieved at
high concentrations of all of the cobamides was indistinguishable (Fig. S4A to G).
However, the concentration of cobamides required to achieve half of the maximal
OD600 (50% effective concentration [EC50]) differed based on the cobamide provided
(Fig. 5). Consistent with the binding data, CNCbl had the lowest EC50 value. EC50 values
for CN[Bza]Cba and CN[2-MeAde]Cba were 5-fold higher than CNCbl, and other cob-
amides had EC50 values 2 orders of magnitude higher than CNCbl.
With the notable exception of the phenolyl cobamides, differences in the EC50
values of cobamides in vivo qualitatively correlated with the binding selectivity that we
observed in vitro (Fig. 2). Among benzimidazolyl cobamides, EC50 values increased from
cobalamin to [Bza]Cba to [5-OHBza]Cba, consistent with the relative binding affinities
of these cobamides. Similarly, [2-MeAde]Cba, which had an intermediate binding
affinity for SmMCM, had a lower EC50 value than [Ade]Cba, which did not bind to
SmMCM at low-micromolar concentrations in vitro. The ability of [5-OHBza]Cba and
[Ade]Cba to support growth suggests that these cobamides can bind SmMCM at
concentrations higher than those tested in vitro; a control experiment with an S. meliloti
strain lacking MCM rules out the possibility that high concentrations of cobamides
(10 M) abiotically enable growth on isoleucine and valine (Fig. S3).
We considered the possibility that differences in cobamide internalization by S.
meliloti could also influence the EC50 measurements shown in Fig. 5. When S. meliloti
cultures were supplemented with equimolar amounts of CNCbl, CN[Ade]Cba, or CN-
[Cre]Cba, the concentration of cobalamin extracted from the cellular fraction was 2- to
3-fold higher than [Ade]Cba and 5- to 6-fold higher than [Cre]Cba (Fig. S5A). This result
suggests that cobamides are differentially internalized or retained by the cells. How-
ever, MCM-dependent growth does not correlate with intracellular cobamide concen-
trations, as intracellular concentrations of cobalamin comparable to those of [Ade]Cba
and [Cre]Cba supported S. meliloti growth to high densities (Fig. S5). Therefore, the high
EC50 of CN[Ade]Cba relative to CNCbl is more likely attributable to enzyme selectivity.
Additional factors that could explain the high EC50 values of the phenolyl cobamides
are considered in Discussion.
Identification of structural elements that interfere with cobamide binding.
Given the apparent importance of MCM cobamide binding selectivity for the cobamide-
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FIG 5 MCM-dependent growth of S. meliloti cobD::gus Gmr metH::Tn5 ΔnrdJ pMS03-nrdABEc with various cobamides (see
also Fig. S3, S4, and S5). (A) Dose dependence of growth based on OD600 at 145 h. Data points and error bars represent
the mean and standard deviation, respectively, for three biological replicates from a single experiment. (B) EC50 values
are the average and standard deviation for five or more biological replicates across two or more independent
experiments.
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dependent growth of S. meliloti, we pursued a more mechanistic understanding of how
lower ligand structure affects cobamide binding. When cobamides are bound to MCM,
the lower ligand is surrounded by protein residues (61, 97). Therefore, the reduced
affinity of certain cobamides for the enzyme could be a result of exclusion of their lower
ligands from this binding pocket because of steric or electrostatic repulsion. We
hypothesized that the poor binding of the purinyl cobamides Ado[Ade]Cba and
Ado[2-MeAde]Cba is due to the presence of the exocyclic amine based on several
observations: (i) Ado[5-OHBza]Cba, which also contains a polar functional group, had
impaired binding to SmMCM (Fig. 2A and C). (ii) In the crystal structure of HsMCM (97),
residues Phe722 and Ala731, which are conserved in SmMCM, would be expected to
electrostatically occlude the exocyclic amine of [Ade]Cba (Fig. S6A, asterisk). Based on
sequence alignment (Fig. S2A), polar residues Tyr and Ser would be expected to occupy
the corresponding positions in EcMCM, which has higher affinity for purinyl cobamides.
(iii) Structural modeling of Ado[Ade]Cba bound to HsMCM, which shares 59% amino
acid identity to SmMCM in the B12-binding domain, suggests significant displacement
of the adenine lower ligand relative to the lower ligand of AdoCbl, in the direction that
would be consistent with steric or electrostatic repulsion of the exocyclic amine by
surrounding residues (Fig. S6B to D).
To test the importance of the exocyclic amine of adenine in cofactor exclusion, we
produced an unsubstituted purinyl cobamide, Ado[Pur]Cba (39). Ado[Pur]Cba also had
low affinity for SmMCM (Fig. 6A and B), suggesting that the exocyclic amine of adenine
is not a major cause of binding exclusion. Consistent with this result, a novel benzimi-
dazolyl cobamide, Ado[7-AmBza]Cba, bound SmMCM with comparable affinity as
Ado[Bza]Cba, despite being functionalized with an exocyclic amine (Fig. 6A and B).
Rather, these results suggest that the presence of nitrogens in the six-membered ring
of the lower ligand interferes with binding. To test this hypothesis directly, we pro-
duced three cobamide analogs with at least one nitrogen in the six-membered ring of
the lower ligand base. Comparison of the binding of Ado[7-MeBza]Cba and Ado[6-
MePur]Cba (Fig. 6A and B) supported a role of ring nitrogens in binding inhibition, and
comparison of binding affinities between Ado[Bza]Cba and Ado[6-AzaBza]Cba (105)
(Fig. 2A and C and Fig. 6A and B, respectively), and between Ado[7-AmBza]Cba and
Ado[3-DeazaAde]Cba (Fig. 6A and B), revealed that a single nitrogen atom in the
six-membered ring of the lower ligand was sufficient to severely impair binding.
As it was recently discovered to be a naturally occurring cobamide (39), we
tested the MCM-dependent growth of S. meliloti with [Pur]Cba. [Pur]Cba had a high
EC50 value of 0.6 0.2 M (Fig. S4H), further supporting the correlation between
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binding and growth that we previously observed for benzimidazolyl and purinyl
cobamides.
DISCUSSION
Cobamides are distinct from other cofactors in their extensive structural diversity,
with over a dozen forms that differ in the lower ligand base and nucleotide loop. How
cobamide lower ligand structure influences the activity of cobamide-dependent en-
zymes has not been extensively explored. Here, we report a systematic analysis of the
effects of cobamide lower ligand structure on the function of a model cobamide-
dependent enzyme, MCM. Our results show that MCM exhibits varied affinities for
different cobamides and that this selectivity is linked to the physiology of the organism.
Our results show that the major determinant of cobamide selectivity in SmMCM is
binding, with small changes in the lower ligand capable of dramatically altering the
binding affinity of a cobamide. One explanation for these differences is that the
chemical compatibility between the lower ligand base and the binding pocket of
the protein strongly influences the binding affinity of cobamides; repulsion of the lower
ligand on the basis of electrostatics could reduce the binding affinity of cobamides to
MCM. While the structure of SmMCM has not been determined, a model generated by
sequence alignment to HsMCM suggested a highly hydrophobic lower ligand binding
pocket. Consistent with this, we observed higher affinity of cobamides with hydropho-
bic lower ligands to SmMCM, as well as interference of ring nitrogens with cobamide
binding.
On the other hand, sequence alignments suggested that many of the hydrophobic
residues predicted to immediately surround the lower ligand are conserved between
diverse MCM orthologs that differ in cobamide selectivity. Assuming that the arrange-
ment of the lower ligand binding pocket is similar across MCM orthologs, this suggests
that interactions within the lower ligand binding pocket are not sufficient to account
for selectivity. In a similar vein, examination of the residues surrounding the lower
ligand in the cobamide-bound structures of reductive dehalogenases does not reveal
the basis of exclusion of certain cobamides (49). These observations suggest that the
lower ligand may have an unknown role in the binding of cobamides to MCM.
Consistent with this idea, studies of the kinetics and pH dependence of AdoCbl binding
to P. shermanii MCM suggest a preassociation step, wherein a cofactor-protein complex
is formed prior to displacement of the lower ligand of the cofactor by a histidine
residue in the protein (89). The nature of this complex is unknown, but potential
interactions between the lower ligand and this conformation of the enzyme could
provide an opportunity for lower ligand structure to impact the outcome of binding.
Our analysis of MCM orthologs from E. coli and V. parvula demonstrates that
variations in cobamide selectivity have evolved in organisms with different physiolo-
gies. The cobamide selectivity patterns in the three MCM orthologs we examined
correlate with the physiologies of the bacteria in two ways. First, in all three cases, each
MCM ortholog has highest affinity for the native cobamide produced by the organism,
suggesting that cobamide biosynthesis and selectivity of cobamide-dependent en-
zymes have coevolved. Second, SmMCM is more selective than EcMCM and VpMCM,
which is consistent with differences in cobamide biosynthesis, acquisition, and use in
these organisms. S. meliloti synthesizes cobalamin de novo and is incapable of attaching
purinyl and phenolyl lower ligands to cobamide precursors (96). Thus, its cobamide-
dependent enzymes have likely evolved to function best with cobalamin. In contrast, E.
coli does not synthesize cobamides de novo and instead relies on the importer BtuBFCD
to acquire cobamides from the environment (106, 107). Alternatively, E. coli can
produce a variety of benzimidazolyl and purinyl cobamides when provided with
precursors (95), making the ability to use multiple cobamides likely advantageous. Like
S. meliloti, V. parvula synthesizes cobamides de novo but can produce both benzimi-
dazolyl and phenolyl cobamides (96, 108) and also encodes membrane transport
components adjacent to cobalamin riboswitches (109), which are likely to be cobamide
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importers (52, 110). Thus, the ability of VpMCM to bind diverse cobamides is similarly
consistent with its physiology.
Relative to cobamide binding selectivity, our results suggest that effects of lower
ligand structure on the catalytic activity of MCM are minor. Among the cobamides we
tested, the maximum differences in SmMCM turnover were 3-fold. We did not observe
inhibition of MCM activity with any cobamides, in contrast to the strong inhibition that
has been observed with analogs containing variations in the upper ligand or central
metal, known as antivitamins (111–113).
In addition to elucidating the biochemical basis of cobamide selectivity in MCM, a
major aim of our work was to link biochemical selectivity with cobamide-dependent
growth. Our results with benzimidazolyl and purinyl cobamides support the hypothesis
that enzyme selectivity is a major determinant of cobamide-dependent growth. Inter-
estingly, although phenolyl cobamides bound SmMCM with high affinity and sup-
ported catalysis in vitro, high concentrations were required to support growth of S.
meliloti. This discrepancy can be partially explained by poorer internalization or reten-
tion of these cofactors compared to cobalamin (see Fig. S5 in the supplemental
material). The observation that the intracellular cobamide concentrations were 50- to
190-fold greater than the amount added to the growth medium (Fig. S5A) suggests that
cobamides could be internalized by an uptake mechanism that favors cobalamin,
distinct from both BtuBFCD and ECF-CbrT (114, 115), both of which are absent from S.
meliloti. Thus, we propose a model in which the cobamide-dependent growth of
bacteria is influenced not only by binding selectivity of cobamide-dependent enzymes
but also by cobamide import (Fig. 7). The lower effectiveness of phenolyl cobamides in
supporting growth of S. meliloti could additionally be explained by inefficient adeno-
sylation of these cobamides in vivo, as MCM requires the adenosyl upper axial ligand for
activity. Whether or not adenosyltransferase enzymes, specifically CobA and PduO (116,
117) in S. meliloti, are selective with respect to lower ligand structure is unknown.
We and others have proposed the possibility of manipulating microbial communi-
ties using cobamides by taking advantage of the differential cobamide-dependent
growth of bacteria (39, 118–120). Cobamides are predicted to mediate microbial
interactions that are critical to the assembly of complex communities (33, 41, 45, 50,
121–124), so the ability to selectively inhibit or promote the growth of particular
species using corrinoids with various lower ligands could be applied to alter the
composition of microbial communities in ways that could promote environmental and
human health. This possibility hinges on the ability to predict which cobamides support
or inhibit growth of an organism of interest, which requires an understanding of the
major biochemical determinants of growth. We observed here that the cobamide
binding selectivity of a model base-off cobamide-dependent enzyme correlates with
growth to a large extent. Thus, uncovering protein residues that confer selectivity
would enable prediction of selectivity in cobamide-dependent enzymes, thereby facil-
itating prediction of the cobamide requirements of organisms of interest. Furthermore,
our results suggest that additional steps of cobamide trafficking may be important
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FIG 7 Model describing biochemical determinants of cobamide-dependent growth in bacteria. Cobamides differentially impact
bacterial growth due to selective cobamide import and biosynthesis, cobamide-binding selectivity of cobamide-dependent enzymes,
and cobamide-dependent catalysis. For MCM-dependent growth of S. meliloti, cobamide-binding selectivity is most strongly correlated
with cobamide-dependent growth of the organism.
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determinants of cobamide-dependent growth. Future studies to understand how these
various steps depend on cobamide structure will ultimately allow us to better under-
stand, predict, and manipulate microbial interactions.
MATERIALS AND METHODS
Chemical reagents. Chemicals were obtained from the sources indicated: 5=-chloro-5=-
deoxyadenosine, Santa Cruz Biotechnology; 7-methylbenzimidazole, Accela; 5-methyl-1H-benzimidazole,
Acros Organics; phenol, J. T. Baker; zinc metal, Fisher Scientific; 5-methoxybenzimidazole, purine, and
para-cresol, Alfa Aesar; methylmalonyl-CoA, methylmalonic acid, coenzyme A, adenosylcobalamin (co-
enzyme B12), cyanocobalamin, dicyanocobinamide, 6-methylpurine, 1H-imidazo[4,5-c]pyridine-4-amine
(3-deazaadenine), benzimidazole, adenine hemisulfate, 5-azabenzimidazole, 1H-benzo[d]imidazol-7-
amine (7-aminobenzimidazole), 2-methyl-1H-purine-6-amine (2-methyladenine), and bovine serum al-
bumin (BSA), Sigma.
Molecular cloning, protein expression, and purification. SmMCM (locus SM_b20757, bhbA) was
expressed from the pET28a vector, with an N-terminal hexahistidine (6His) tag, in E. coli BL21(DE3)pLysS
(cloning primers are listed in Table S1 in the supplemental material). The expression strain was grown to
an optical density at 600 nm (OD600) of 0.6 to 0.8 at 37°C, cooled on ice for 15 min, and induced with
1 mM isopropyl--D-thiogalactopyranoside (IPTG) for 2.5 h at 37°C. Cells were lysed by sonication in
25 mM Tris-HCl, pH 8.0, 300 mM NaCl, 10 mM imidazole, with 0.5 mM phenylmethylsulfonyl fluoride
(PMSF), 1 g/ml leupeptin, 1 g/ml pepstatin, and 1 mg/ml lysozyme. Clarified lysate was treated with
0.05% polyethyleneimine. An Äkta Pure 25 fast protein liquid chromatography (FPLC) system was used
to purify the protein over a GE 5-ml HisTrap HF column, using a gradient of 21 to 230 mM imidazole in
the lysis buffer. Purified protein was dialyzed into 25 mM Tris-HCl, pH 8.0, 300 mM NaCl, 10% glycerol and
concentrated with a Vivaspin 10,000-molecular-weight-cutoff (MWCO) protein concentrator. Purity was
analyzed by SDS-PAGE (Fig. S7), and protein concentration was determined by A280 using the theoretical
extinction coefficient 55,810 M1 cm1 (125). EcMCM (locus b2917, scpA, previously sbmA) was expressed
with an N-terminal 6His tag from a pET28a vector in E. coli BL21(DE3), by induction at an OD600 of 0.6
to 0.8 with 0.1 mM IPTG, for 3.5 h at 30°C. The protein was purified as described above, and the final
concentration was determined by Coomassie blue-stained SDS-PAGE (Fig. S7), using BSA as a standard.
The V. parvula genome has two MCM annotations: a heterotetramer (loci Vpar_RS06295 and
Vpar_RS06290) and a heterodimer (loci Vpar_RS09005 and Vpar_RS09000). The functionality of both
homologs was tested by complementation in S. meliloti. The two putative VpMCM enzymes were cloned
into the pTH1227 vector and transferred by conjugation into an S. meliloti bhbA::Tn5 mutant. Comple-
mentation was assessed by growth in M9 liquid medium containing L-isoleucine and L-valine (see “S.
meliloti growth assays” below for additional details). S. meliloti coexpressing Vpar_RS09005 and
Vpar_RS09000 showed identical growth to a strain expressing SmMCM from pTH1227 and was selected
for in vitro studies.
The  subunit of VpMCM (encoded by Vpar_RS09005) was expressed with an N-terminal 6His tag
from the pET-Duet expression vector in E. coli BL21(DE3). Protein expression was induced with 520 M
IPTG for 6 h at 30°C. The protein was batch purified by nickel affinity and subsequently purified by FPLC
using a HiTrapQ column with an NaCl gradient from 50 to 500 mM in 20 Tris-HCl, pH 8.0, 10% glycerol.
The  subunit of VpMCM (encoded by Vpar_RS09000) was expressed separately with an N-terminal
6His tag from the pET-Duet expression vector in E. coli BL21(DE3). Expression was induced with 1 mM
IPTG for 22 h at 16°C, and the protein was purified using nickel-affinity chromatography as described for
SmMCM. Purified protein was dialyzed into 25 mM Tris-HCl, pH 8.0, 300 mM NaCl, 10% glycerol, and 1 mM
-mercaptoethanol. Concentration of pure  and  subunits (Fig. S7) was determined by absorbance at
280 nm (A280) using the theoretically calculated extinction coefficients 75,290 M1 cm1 and 74,260
M1 cm1, respectively (125). Equimolar amounts of  and  subunits were combined during the setup
of fluorescence binding assays.
E. coli thiokinase containing an N-terminal 6His tag was expressed from a vector provided by
Gregory Campanello from the laboratory of Ruma Banerjee. Expression was induced with 1 mM IPTG in
E. coli BL21(DE3)pLysS at 28°C for 3 h. The protein was purified as a heterodimer using nickel-affinity
chromatography as described above. His-tagged Rhodopseudomonas palustris MatB (126) was expressed
from a pET16b expression plasmid provided by Omer Ad from the laboratory of Michelle Chang. The
protein was overexpressed in E. coli BL21(DE3) at 16°C overnight, after induction with 1 mM IPTG, and
purified by nickel-affinity chromatography as indicated above. Thiokinase and MatB concentrations were
determined by Coomassie blue-stained SDS-PAGE, using BSA as a standard.
Guided biosynthesis, extraction, and purification of cobamides. Sporomusa ovata strain DSM
2662 was used for the production of its native cobamide, [Cre]Cba, and for production of [Phe]Cba,
[5-MeBza]Cba, [Bza]Cba, [5-OHBza]Cba, [7-MeBza]Cba, and [7-AmBza]Cba, by guided biosynthesis as
previously described (44). 5-OHBza was synthesized as described previously (96). Salmonella enterica
serovar Typhimurium strain LT2 and Propionibacterium acidipropionici strain DSM 20273 were used for
production of [Ade]Cba (47, 127). [2-MeAde]Cba, [Pur]Cba, [6-AzaBza]Cba, [3-DeazaAde]Cba, and [6-
MePur]Cba were produced by guided biosynthesis in P. acidipropionici. Cobamides were extracted as
previously described (47) and purified by high-performance liquid chromatography (HPLC) using previ-
ously published methods (47, 96, 128) as well as additional methods listed in Table S2. In many cases,
more than one method was required to achieve high purity. Identity of cobamides was confirmed by
liquid chromatography (LC) coupled to mass spectrometry (MS) using an Agilent 1260 LC/6120 quad-
rupole MS instrument. The orientation of the lower ligands of [7-MeBza]Cba, [7-AmBza]Cba, [3-
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DeazaAde]Cba, and [6-MePur]Cba is likely to be analogous to the lower ligand orientation in purinyl
cobamides (127, 129). This assumption is supported by the absorbance spectra of these cobamides under
acidic conditions, which reveal a base-on conformation (Fig. S8); the opposite orientation of the amino
and methyl substituents would create steric interference between the lower ligand and corrin ring, which
would be expected to weaken the coordination bond and favor a base-off conformation, especially at
low pH. The orientation of the lower ligands in [Pur]Cba and [6-AzaBza]Cba was not determined.
Chemical adenosylation of cobamides. Cobamide adenosylation was performed as previously
described (128, 130). Briefly, cobamides at concentrations of 0.5 to 1 mM were reduced with activated
zinc metal under anaerobic conditions, with vigorous stirring for 0.5 to 2 h. 5=-Chloro-5=-deoxyadenosine
was added, and adenosylation was allowed to proceed for 1 to 3 h in the dark. The progress of the
reaction was monitored by HPLC. Following adenosylation, cobamides were desalted using a C18 SepPak
(Waters), purified by HPLC, desalted again, dried, and stored at 20°C or 80°C.
Cobamide quantification. Purified cobamides were dissolved in water and quantified by UV-Vis
spectrophotometry on a BioTek Synergy 2 plate reader using the following extinction coefficients: for
cyanylated benzimidazolyl cobamides, 518  7.4 103 M1 cm1 (131); for cyanylated purinyl cobam-
ides, 548  7.94 103 M1 cm1 (132); for cyanylated phenolyl cobamides, 495  9.523 103
M1 cm1 (133); for adenosylated benzimidazolyl cobamides (AdoCbl, Ado[5-MeBza]Cba, Ado[Bza]Cba,
Ado[5-OHBza]Cba, Ado[7-MeBza]Cba, and Ado[7-AmBza]Cba), which are predominantly base-on in
water, 522  8.0 mM1 cm1 (131); for adenosylated purinyl cobamides (Ado[Ade]Cba, Ado[2-
MeAde]Cba, and Ado[Pur]Cba), which are predominantly base-off in water, and phenolyl cobamides
(Ado[Cre]Cba and Ado[Phe]Cba), which are base-off, 458  8.8 mM1 cm1 (132); for adenosylated
azabenzimidazolyl cobamides (Ado[3-DeazaAde]Cba, Ado[6-AzaBza]Cba, and Ado[6-MePur]Cba), which
are a mixture of base-on and base-off in water, the concentration was estimated from the average of
concentrations calculated using the extinction coefficients above.
Fluorescence binding assays. An in vitro assay previously described for measuring binding of
AdoCbl to P. shermanii MCM (89) was adapted to a 96-well format: MCM (0.2 M) was combined with a
range of cobamide concentrations (as specified in each experiment) in a black 96-well plate in 50 mM
potassium phosphate, pH 7.5, with 1 mM dithiothreitol (DTT), on ice. All steps involving cobamides were
conducted in the dark. The plate was centrifuged for 1 min at 3,800 rpm to level the surface of the liquid
in each well. The plate was then incubated for 40 min at 30°C to allow binding, with a brief shaking step
after 30 min. Preliminary experiments showed that this time is sufficient for equilibration. Following
incubation, fluorescence emission at 340 nm (5-nm slit width) was measured upon excitation at 282 nm
(5-nm slit width) using a Tecan Infinite M1000 Pro plate reader. Fluorescence, normalized to the initial
value, was plotted as a function of cobamide concentration, and fitted to the following equation (134):
F
F0
 1
Fmax
F0
([E] [L] Kd)	([E] [L] Kd)2	 4[E][L]
2[E]
where F is fluorescence, F0 is initial fluorescence, [E] is total enzyme concentration, [L] is total ligand
concentration, and Kd is the binding dissociation constant.
Filtration binding assay. Cobamides (10 M) with and without MCM (15 M) were incubated in 100
mM Tris, 50 mM phosphate, pH 7.5, at 30°C for 40 min, transferred to Nanosep 10K Omega centrifugal
devices (Pall Corporation), and centrifuged for 5 min at 13,900 g to separate unbound cobamides from
enzyme-bound cobamides. The UV-Vis spectra of the filtrates were recorded on a BioTek Synergy 2 plate
reader.
Structural modeling. A model of SmMCM was generated using the Swiss-Model software (135)
based on the known crystal structure of Homo sapiens MCM (HsMCM) (PDB ID 2XIJ) (97). No major
differences were observed in the B12-binding domain between SmMCM models generated from HsMCM
and Propionibacterium freudenreichii MCM (PDB ID 4REQ) (61).
Maestro (136) was used to generate a model of HsMCM bound to [Ade]Cba. The initial structure
of HsMCM bound to cobalamin (PDB ID 2XIQ) (97) was prepared using standard methods. A
constrained energy minimization (atoms within 10 Å of cobalamin freely moving; atoms within a
second 10-Å shell constrained by a force constant of 200; remaining structure frozen) was performed
using MacroModel (137). The structure of the lower ligand was then modified to adenine, and the
constrained energy minimization was repeated to generate a model of the lower ligand binding
pocket bound to [Ade]Cba.
Enzymatic synthesis of (R)-methylmalonyl-CoA. (R)-Methylmalonyl-CoA synthesis reaction mix-
tures contained the following in 10 ml: 100 mM sodium phosphate (pH 7.5), 20 mM MgCl2, 5 mM ATP,
10 mM methylmalonic acid, 2 mM coenzyme A, 5 mM -mercaptoethanol, and 1.5 M purified MatB
protein. After combining ingredients on ice, the reaction mixture was incubated at 37°C for 1 h. The
reaction mixture was then frozen in liquid nitrogen and lyophilized. To purify (R)-methylmalonyl-CoA, the
dried reaction mixture was resuspended in 3.2 ml water, the protein was precipitated with 200 l
trichloroacetic acid, precipitate was pelleted, supernatant was neutralized with 200 l of 10 M NaOH, and
salts and remaining starting materials were removed using a C18 SepPak column (Waters) (loaded in 0.1%
formic acid and washed with water, methylmalonyl-CoA was eluted with 50% methanol in water).
Formation of (R)-methylmalonyl-CoA was initially verified by 1H nuclear magnetic resonance (NMR) and
in subsequent preparations by HPLC (Table S2). The concentration of (R)-methylmalonyl-CoA was
determined using an extinction coefficient of 12.2 mM1 cm1 at 259 nm.
MCM activity assays. A thiokinase-coupled, spectrophotometric MCM activity assay was adapted
from previous work (138), except that ADP was used instead of GDP, and the experiment was conducted
in 96-well plates. Final concentrations of reagents in the assays were as follows: Tris-phosphate buffer (pH
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7.5), 100 mM Tris, 50 mM phosphate; dithionitrobenzoate (DTNB), 400 M; ADP, 1 mM; MgCl2, 10 mM;
(R)-methylmalonyl-CoA, 0 to 4 mM; thiokinase, 5 M; MCM, 50 nM; and cobamides, 2 M. Preliminary
experiments were conducted to ensure that concentrations of thiokinase, DTNB, and cobamides were
not rate limiting.
Three separate mixes were prepared, all in 1 Tris-phosphate buffer: an assay mix containing DTNB,
ADP, and MgCl2; a substrate mix containing (R)-methylmalonyl-CoA; and an enzyme mix containing
thiokinase, MCM, and cobamides. All steps involving cobamides were conducted in the dark. The assay
and enzyme mixes were prepared as a master mix and aliquoted into 96-well plates; substrate mixes
were prepared in individual wells, in triplicate. All components were incubated at 30°C for 40 min to
equilibrate temperature and allow prebinding of cobamides and MCM. After incubation, one replicate at
a time, the substrate mix was added to the assay mix, followed by the enzyme mix. Absorbance at
412 nm (A412) was recorded immediately after addition of enzyme and for 1 to 3 min, every 3 s, on a
BioTek Synergy 2 plate reader. The increase in A412 in reaction mixtures lacking substrate was subtracted
from all readings, to account for reactivity of DTNB with thiols on protein surfaces. A412 values were
converted to concentration of free CoA using a path-length correction determined for the reaction
volume and extinction coefficient of 14,150 M1 cm1.
S. meliloti growth assays. MCM-dependent growth experiments were performed with S. meliloti
strain Rm1021 cobD::gus Gmr metH::Tn5 ΔnrdJ pMS03-nrdABEc, which lacks cobamide-dependent en-
zymes other than MCM and does not synthesize cobalamin. cobD is required for cobalamin biosynthesis
(139), metH encodes methionine synthase (139–141), and nrdJ encodes ribonucleotide reductase (142).
Because nrdJ is essential, the E. coli cobamide-independent ribonucleotide reductase encoded by nrdA
and nrdB was expressed from the pMS03 plasmid (143). The strain was precultured in M9 medium (144)
(modified concentration of MgSO4: 1 mM) containing 0.1% sucrose, 2 g/liter isoleucine, 2 g/liter valine,
1 g/liter methionine, and 20 g/ml gentamicin, with shaking at 30°C. After 2 days, cells were washed and
diluted to an OD600 of 0.02 into M9 medium containing 4 g/liter isoleucine, 4 g/liter valine, 1 g/liter
methionine, 20 g/ml gentamicin, and cobamides at various concentrations as indicated for each
experiment, in 384-well plates. The plates were incubated at 30°C for 145 h in a BioTek Synergy 2 plate
reader with linear shaking at 1,140 cpm. OD600 was measured in 1-h increments.
For quantification of intracellular cobamides in S. meliloti, the strain above was precultured as
described above, diluted into 50 ml of M9 medium containing 0.2% sucrose and various cobamides, and
grown for 48 h (until OD600 reached 0.6 to 0.8). Cobamides were extracted from cell pellets as previously
described (47), using 5 ml of methanol containing 500 g of potassium cyanide. A partial purification by
means of a wash step with 20% methanol in water was included during the SepPak desalting procedure.
Extracted cobamides were quantified by HPLC using peak areas at 525 nm and external standard curves,
and cellular cobamide concentrations were calculated assuming 8 108 cells/ml at an OD600 of 1.0 and
a cellular volume of 1 m3.
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